Evidence-based treatment planning in mCRC- The key to maximising outcomes

Dirk Arnold; Eric Van Cutsem; Sharlene Gill

European Medical Journal Oncology (Oct 2013)

Evidence-based treatment planning in mCRC- The key to maximising outcomes

Dirk Arnold,
Eric Van Cutsem,
Sharlene Gill

Affiliations

Dirk Arnold: Medical Director of the Hubertus Wald Tumor Center at the University Cancer Center, Hamburg, Germany
Eric Van Cutsem: Professor of Internal Medicine, Head of Digestive Oncology, University Hospital Gathuisberg, Leuven, Belgium
Sharlene Gill: Associate Professor of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada

Journal volume & issue: Vol. 1, no. 1
pp. 32 – 37

Abstract

Read online

This Roche sponsored satellite symposium was held as part of the European Cancer Congress 2013, and reviewed the current evidence available on treatment options for metastatic colorectal cancer and the application of this evidence to clinical practice.

European Cancer Congress

Published in European Medical Journal Oncology

ISSN: 2054-619X (Online)
Publisher: European Medical Journal
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://emjreviews.com/therapeutic-area/oncology/

About the journal

Abstract

Keywords